Physician profile
Heather A Morrow
NPI 1184214082
$1,997.75
in general payments reported to CMS, 2019-2025
17 companies · $430 in 2025
The $430 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $217 · 2023: $135 · 2024: $917 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,481.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $670.57 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Biohaven Pharmaceuticals, INC. | $238.77 | 2021 | |
| Medtronic, INC. | $219.94 | 2022-2025 | Inceptiv, Synchromedii, Intellis Adaptivestim |
| Nevro Corp. | $184.05 | 2023-2024 | Senza |
| Abbvie INC. | $166.87 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $159.03 | 2024 | Relistor |
| Collegium Pharmaceutical, INC. | $62.79 | 2025 | Xtampza, Belbuca |
| Saluda Medical Americas, INC. | $51.02 | 2024 | Evoke |
| Valinor Pharma, LLC | $48.14 | 2024 | Movantik |
| Kowa Pharmaceuticals America, INC. | $33.46 | 2022 | |
| Grt US Holding, INC. | $29.04 | 2021-2022 | |
| Biotronik Nro, INC. | $28.84 | 2024 | Prospera |
| Lilly USA, LLC | $27.22 | 2021 | |
| Relievant Medsystems, INC. | $24.36 | 2023 | Intracept |
| Nalu Medical, INC. | $20.95 | 2024 | Nalu Neurostimulation System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.98 | 2025 | |
| International Rehabilitative Sciences, INC | $14.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Morrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.